pharmacovigilance risk-benefit optimisation … november 2010 pharmacovigilance regulatory science...

2

www.pharminvent.com November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics Biosimilars Generics Small molecules Centrally authorised Decentralised procedures Mutually recognised Nationally authorised

Upload: ledat

Post on 07-Apr-2018

223 views

Category:

Documents

2 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics ... November

www.pharminvent.com November2010

Pharmacovigilance

Regulatory Science

Risk Management

Risk-benefit optimisation

Advanced Therapies

Biologics

Biosimilars

Generics

Small molecules

Centrally authorised

Decentralised procedures

Mutually recognised

Nationally authorised

Page 2: Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics ... November

www.pharminvent.com November2010

PharmInvent is led by experienced

EU ex-regulators, including former

members of CHMP and PhVWP, EMA

managers, as well as ICH and CIOMS

expert group members.

Medication Errors - Experience of Pharmacovigilance Risk ... · Medication Errors . Experience of Pharmacovigilance Risk Assessment Committee with use of regulatory tools. Dr June

Pharmacovigilance and Risk Management Strategies Conference · The Pharmacovigilance and Risk Management Strategies Conference promises to be the best instalment yet in this acclaimed

Pharmacovigilance Risk Management Signal Detection … · safety/pharmacovigilance, risk management, signal detection, and assessment – as a . ... (Eudravigilance, FDA) • xEVMPD

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 May 2015 . EMA/PRAC/332948/2015 . Procedure Management and Committees Support Division . Pharmacovigilance Risk Assessment

Plant Design Optimisation & Risk Assessment (HAZOP) · PDF filePlant Design Optimisation & Risk Assessment (HAZOP) ... Project ManagementPlant Design Optimisation & Risk Assessment

Pharmacovigilance Risk Assessment Committee (PRAC) · 27 November 2017 EMA/PRAC/785853/2017 Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance

Pharmacovigilance Risk Assessment Committee (PRAC)€¦ · 7 February 2013 . EMA/91065/2013 . Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment

Pharmacovigilance Risk Assessment Committee (PRAC) · 10 October 2013 . EMA/PRAC/586155/2013 . Pharmacovigilance Risk Assessment Comm ittee (PRAC) Pharmacovigilance Risk Assessment

Pharmacovigilance and Risk Management Chapter 17

Pharmacovigilance and Risk Management - PRISME … 21, 2003 · Pharmacovigilance and Risk Management Uwe Trinks, CIO Sentrx PRISM Forum Special Interest Group BMS, Lawrenceville,

Safety reports rmp risk management plan pharmacovigilance

Guideline on good pharmacovigilance practices: Module V - Risk

Pharmacovigilance Risk Assessment Committee (PRAC) · 3 April 2017 EMA/PRAC/227083/2017 Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance Risk

Pharmacovigilance Risk Assessment Committee (PRAC) · 6 February 2014 EMA/158631/2014 Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment Committee

Guideline on good pharmacovigilance practices: Module V - Risk

ENCePP Plenary: New Pharmacovigilance legislation · An agency of the European Union Peter Arlett. Head of Pharmacovigilance and Risk Management. EMA. ENCePP Plenary: New Pharmacovigilance

Pharmacovigilance Risk Assessment Committee …...Pharmacovigilance Risk Assessment Committee (PRAC) EMA/PRAC/59170/2015 Page 2/83 Table of contents 1. Introduction 11 1.1. Welcome

Pharmacovigilance Risk Assessment Committee (PRAC) · Pharmacovigilance Risk Assessment Committee (PRAC)

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 March 2013 . EMA/162000/2013 . Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment Committee

Pharmacovigilance and Risk Management Strategies Forum

Pharmacovigilance Risk Assessment Committee (PRAC) · 7 April 2015 . EMA/PRAC/59170/2015 . Procedure Management & Business Support Division . Pharmacovigilance Risk Assessment Committee

Pharmacovigilance in Japan and Risk Management …Streamlined risk management strategies (pending) 4 renewal renewal Pharmacovigilance strategies including Pharmacovigilance Plan will

Presentation: Pharmacovigilance - a regulator's perspective · – Summary of Safety Concerns – Pharmacovigilance Plan – Risk Minimisation Plan – Australian-specific Annex

The Pharmacovigilance Risk Assessment Committee J. Williams - The... · The Pharmacovigilance Risk Assessment Committee GPvP Symposium, 14 March 2014 Dr Julie Williams, PRAC Delegate

Pharmacovigilance Risk Assessment Committee (PRAC) · 16 May 2013 . EMA/PRAC/332071/2013 Corr. Pharmacovigilance Risk Assessment Committee (PRAC) Pharmacovigilance Risk Assessment

Benefit-risk evaluation and Pharmacovigilance Planning

Pharmacovigilance and Risk Management Strategies Conference · Pharmacovigilance and Risk Management Strategies Conference Short Courses: January 19-22, 25 | Conference: January 26-28

Pharmacovigilance Risk Assessment Committee (PRAC)

Principles of Signal Detection & Risk Management in Pharmacovigilance

Pharmacovigilance Risk Assessment Committee(PRAC )€¦ · 11 January 2016 . EMA/PRAC/22240/2016 . Procedure Management and Committees Support Division . Pharmacovigilance Risk Assessment

Pharmacovigilance Risk Assessment Committee (PRAC) · 30 August 2016 EMA/PRAC/579871/2016 *Rev.1 Procedure Management and Committees Support Division Pharmacovigilance Risk Assessment

Minimizing Risk in Pharmacovigilance

Pharmacovigilance Risk Assessment Committee (PRAC)...2016/10/27 · 24 October 2016 EMA/PRAC/637685/2016 Inspections, Human Medicines Pharmacovigilance & Committees Division Pharmacovigilance

Pharmacovigilance Risk Assessment Committee (PRAC) · Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance Risk Assessment Committee (PRAC) Minutes

Pharmacovigilance Risk Assessment Committee (PRAC)...EMA/PRAC/459031/2020 Human Medicines Division Pharmacovigilance Risk Assessment Committee (PRAC) Draft agenda for the meeting on